PortfoliosLab logo

Anixa Biosciences, Inc. (ANIX)

Equity · Currency in USD · Last updated Oct 1, 2022

Company Info

ISINUS03528H1095
CUSIP03528H109
SectorHealthcare
IndustryDiagnostics & Research

Trading Data

Previous Close$6.14
Year Range$2.50 - $6.15
EMA (50)$4.23
EMA (200)$3.78
Average Volume$83.62K
Market Capitalization$178.86M

ANIXShare Price Chart


Chart placeholderClick Calculate to get results

ANIXPerformance

The chart shows the growth of $10,000 invested in Anixa Biosciences, Inc. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,174 for a total return of roughly -68.26%. All prices are adjusted for splits and dividends.


0.00%50.00%100.00%MayJuneJulyAugustSeptember
78.92%
-21.76%
ANIX (Anixa Biosciences, Inc.)
Benchmark (^GSPC)

ANIXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M17.70%-10.05%
6M79.56%-20.85%
YTD65.66%-24.77%
1Y3.58%-17.75%
5Y13.36%7.32%
10Y0.36%9.46%

ANIXMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202210.44%-15.24%-1.44%18.61%10.46%-14.76%24.18%9.74%17.99%
202118.89%38.63%-7.51%4.27%-18.65%-2.27%13.92%26.70%-14.82%-0.00%-23.69%-18.41%
20208.23%-15.77%-46.82%18.87%20.63%34.21%-9.15%-28.78%22.73%-15.23%28.16%16.29%
201930.20%-1.36%-10.67%-7.96%0.24%-12.95%29.20%-15.32%0.72%-3.25%-1.03%-14.36%
201858.05%-11.80%16.72%-2.86%-5.63%-13.92%8.58%15.81%21.78%-12.72%-3.21%0.51%
2017-9.26%-19.39%-24.05%-35.00%-56.92%36.90%-31.30%-15.06%291.95%-22.05%21.95%-5.60%
2016-2.33%-21.09%29.74%-6.31%14.89%-3.09%1.27%27.67%-4.19%63.24%-10.24%-5.26%
2015-2.73%-10.09%37.32%-9.16%8.33%23.08%22.25%-14.31%13.37%-21.68%-24.46%7.12%
20140.00%53.06%0.00%13.33%-13.24%1.69%-13.67%2.70%-9.77%-16.67%-15.00%-35.29%
201333.33%-12.50%-4.76%14.00%44.74%-16.67%-20.73%-0.00%-12.80%2.58%7.18%-6.22%
2012-0.00%63.64%11.11%-17.50%-27.27%-4.17%-0.00%4.35%97.50%9.28%-22.39%-10.45%
2011-19.05%5.88%0.00%26.39%75.82%-10.00%-38.89%-13.64%-18.42%3.23%-20.00%-14.06%
2010-16.13%-5.77%-20.41%-0.00%-17.95%-9.37%-17.24%-6.25%-6.67%2.38%16.28%-16.00%

ANIXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Anixa Biosciences, Inc. Sharpe ratio is 0.04. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MayJuneJulyAugustSeptember
0.04
-0.77
ANIX (Anixa Biosciences, Inc.)
Benchmark (^GSPC)

ANIXDividend History


Anixa Biosciences, Inc. doesn't pay dividends

ANIXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-69.25%
-25.25%
ANIX (Anixa Biosciences, Inc.)
Benchmark (^GSPC)

ANIXWorst Drawdowns

The table below shows the maximum drawdowns of the Anixa Biosciences, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Anixa Biosciences, Inc. is 96.25%, recorded on Aug 15, 2017. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.25%Jan 15, 20101857Aug 15, 2017
-4.84%Jan 6, 20104Jan 11, 20101Jan 12, 20105

ANIXVolatility Chart

Current Anixa Biosciences, Inc. volatility is 134.09%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%MayJuneJulyAugustSeptember
134.09%
19.40%
ANIX (Anixa Biosciences, Inc.)
Benchmark (^GSPC)